Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 52 (RPL21P52)

Target
RPL21P52
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein L21 pseudogene 52 (RPL21P52) is classified as a *pseudogene* referring to a non-functional segment of DNA that is similar to a functional gene—in this case, ribosomal protein L21 (RPL21)[1][7]. Pseudogenes generally do not encode functional proteins owing to mutations or lack of regulatory elements required for their expression. RPL21P52 is identified in the human genome, and alternative aliases such as RPL21_16_474 are used in various genomic resources[7]. As a pseudogene, RPL21P52 is not a therapeutic target, does not encode an active enzyme or receptor, and thus has no known biological functions, disease roles, or drug interactions. The canonical, functional gene for ribosomal protein L21 is RPL21, which encodes a structural component of the 60S ribosomal subunit involved in protein synthesis[4][6]. RPL21P52 does not produce the functional ribosomal protein and is not relevant for therapeutic targeting.

Other names
RPL21_16_474RPL21P52

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 52 (RPL21P52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 52 (RPL21P52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call